Prices delayed by at least 15 minutes | Print
Live UK pricing:
British & American Investment Trust PLC (BAF)
ORD SHS #1Open
8.50p
Previous close
8.50p
Trade high
7.65p
Estimated NAV
8.00
Year high
18.00p
Year low
6.00p
Premium / Discount
-4.38%
Market capitalisation
£1.91 mn
Volume
300
Dividend yield
–
Ongoing charge
13%
ISIN
GB0000653112
This share can be held in a Dealing accountStocks and shares ISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Before investing please read:
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 08/12/2023 | 15/11/2024 |
| Ex-dividend date | 07/12/2023 | 14/11/2024 |
| Payment date | 21/12/2023 | 05/12/2024 |
| Amount | 1.75p | 1.75p |
Net asset value (NAV)
| Estimated NAV | 8.00 |
|---|---|
| Latest actual NAV | 8.00 |
| Latest actual NAV date | 31 July 2026 |
| 12m average premium/discount | 31.21% |
Top 10 holdings
| Holdings 30/06/2024 | % of assets |
|---|---|
| Geron Corp | 56.66 |
| Dunedin Income Growth Inv Trust PLC | 11.12 |
| Lineage Cell Therapeutics Inc | 4.63 |
| abrdn Diversified Income and Growth PLC | 4.12 |
| Serina Therapeutics (Usa) | 0.23 |
| ADVFN PLC | 0.17 |
| Vodafone AG | 0.14 |
| Audioboom | 0.13 |
| Iqe | 0.06 |
| Relief Therapeutics | 0.04 |
Investment objective
The policy is to invest predominantly in investment trusts and other leading UK and US-quoted companies to achieve a balance of income and growth.
Morningstar ratingTM
News
Recent trades
| Date | Time | Price | Quantity | Value (£) |
|---|---|---|---|---|
| 28/08/2026 | 04:40:35 | 7.65 | 300 | 22.95 |
| 27/08/2026 | 02:00:21 | 9.2 | 168 | 15.46 |
| 27/08/2026 | 01:21:13 | 7.66 | 17,550 | 1,344.33 |
| 27/08/2026 | 11:33:53 | 7.68 | 855 | 65.66 |
| 27/08/2026 | 11:00:28 | 9.2 | 2,500 | 230.00 |